BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/25/2020 10:20:16 AM | Browse: 1015 | Download: 1777
 |
Received |
|
2020-10-20 15:26 |
|
Peer-Review Started |
|
2020-10-20 15:27 |
|
First Decision by Editorial Office Director |
|
2020-11-13 16:52 |
|
Return for Revision |
|
2020-11-13 16:52 |
|
Revised |
|
2020-11-24 15:37 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-12-04 12:45 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-12-06 01:46 |
|
Articles in Press |
|
2020-12-06 01:46 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-12-23 04:22 |
|
Publish the Manuscript Online |
|
2020-12-25 10:20 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Gut microbiota mediated molecular events and therapy in liver diseases
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Xiaoqiang Qi, Ming Yang, Joseph Stenberg, Rahul Dey, Leslie Fogwe, Muhammad Shawkat Alam, Eric T Kimchi, Kevin F Staveley-O'Carroll and Guangfu Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| NIH Grant |
R01CA208396 |
| VA Merit Award |
I01 BX004065-1 |
|
| Corresponding Author |
Guangfu Li, DVM, PhD, Assistant Professor, Department of Surgery, University of Missouri, 230 Jesse Hall, Columbia, MO 65212, United States. liguan@health.missouri.edu |
| Key Words |
Gut microbiota; Intrahepatic immunity; Metabolite; Fecal microbial transplantation; Probiotic; Antibiotic |
| Core Tip |
Accumulating evidence shows that gut microbiota plays a critical role in liver pathophysiology and targeting gut microbiota is a potential treatment option for chronic liver disease. Herein, this review explores the cellular and molecular mechanisms of how gut microbiota contributes to liver diseases, including alcohol-induced and nonalcohol-induced liver fatty liver diseases, liver fibrosis, cirrhosis, and cancer. This review also summarizes the current gut microbiota-based therapeutic strategies and discusses future directions in promoting gut microbiota-based therapy for liver diseases. |
| Publish Date |
2020-12-25 10:20 |
| Citation |
Qi X, Yang M, Stenberg J, Dey R, Fogwe L, Alam MS, Kimchi ET, Staveley-O'Carroll KF, Li G. Gut microbiota mediated molecular events and therapy in liver diseases. World J Gastroenterol 2020; 26(48): 7603-7618
|
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i48/7603.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i48.7603 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
